China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294) for CNY 260 million on September 26, 2023. China Resources Double-Crane Pharmaceutical Co.,Ltd. entered into an agreement to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd on September 27, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.19 CNY | +0.36% | +5.50% | -1.45% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
33.19 CNY | +0.36% | +5.50% | 2.32B | ||
22.88 CNY | -1.00% | +5.10% | 3.23B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.45% | 2.32B | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+52.98% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-4.68% | 8.3B |
- Stock Market
- Equities
- 300294 Stock
- News China Resources Boya Bio-pharmaceutical Group Co.,Ltd
- China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million